BRYNJELSEN SEAN
Director, President & CEO · 4 filings · Latest: Aug 19, 2026
Eton Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ETON | BRYNJELSEN SEAN | Director, President & CEO | Aug 20, 2026 | Sale | $60.70 | 91,022 | $5.5M | 961,194 | |
ETON | BRYNJELSEN SEAN | Director, President & CEO | Aug 19, 2026 | Sale | $62.65 | 8,978 | $562.5K | 1,052,216 | |
ETON | BRYNJELSEN SEAN | — | Aug 19, 2026 | Proposed Sale | $63.43 | 100,000 | $6.3M | — | Aug 20 9:01 PM 144/A |
ETON | BRYNJELSEN SEAN | — | Aug 19, 2026 | Proposed Sale | $63.43 | 100,000 | $6.3M | — | |
ETON | BRYNJELSEN SEAN | Director, President & CEO | Jul 14, 2026 | Option Exercise | $1.37 | 200,000 | $274.0K | 1,061,194 | |
ETON | BRYNJELSEN SEAN | Director, President & CEO | Jul 12, 2026 | Option Exercise | — | 27,500 | — | 861,194 | |
ETON | BRYNJELSEN SEAN | Director, President & CEO | May 28, 2026 | Sale | $31.88 | 120,000 | $3.8M | 833,694 | |
ETON | BRYNJELSEN SEAN | — | May 28, 2026 | Proposed Sale | $32.40 | 120,000 | $3.9M | — | |
ETON | BRYNJELSEN SEAN | — | Jan 14, 2026 | Proposed Sale | $15.39 | 5,015 | $77.2K | — | |
ETON | BRYNJELSEN SEAN | — | Dec 12, 2025 | Proposed Sale | $16.88 | 8,035 | $135.6K | — | |
ETON | BRYNJELSEN SEAN | — | Jun 3, 2025 | Proposed Sale | $18.00 | 210,000 | $3.8M | — |